The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6)

FOREWORD  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):485-6

4th International Symposium on TArgeted Radiotherapy and Dosimetry (ISTARD): Best Ranked Abstract Publication

Chiesa C., Luster M., Lassmann M.

PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):487-95

Quantification of activity by alpha-camera imaging and small-scale dosimetry within ovarian carcinoma micrometastases treated with targeted alpha therapy

Chouin N., Lindegren S., Jensen H., Albertsson P., Bäck T.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):496-502

Personalization of radioiodine treatment for Graves’ disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass

Orsini F., Traino A. C., Grosso M., Guidoccio F., Boni G., Volterrani D., Mariani G.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):503-8

A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres

Chiesa C., Mira M., Maccauro M., Romito R., Spreafico C., Sposito C., Bhoori S., Morosi C., Pellizzari S., Negri A., Civelli E., Lanocita R., Camerini T., Bampo C., Carrara M., Seregni E., Marchianò A., Mazzaferro V., Bombardieri E.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):509-14

Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I

Pettinato C., Monari F., Nanni C., Allegri V., Marcatili S., Civollani S., Cima S., Spezi E., Mazzarotto R., Fanti S.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):515-21

Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy)

Bianchi L., Baroli A., Lomuscio G., Pedrazzini L., Pepe A., Pozzi L., Chiesa C.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):522-8

Quantitative evaluation on [90Y] DOTATOC PET and SPECT imaging by phantom acquisitions and clinical applications in locoregional and systemic treatments

Fabbri C., Mattone V., Casi M., De Lauro F., Agostini M., Bartolini N., D’arienzo M., Marchi G., Bartolomei M., Sarti G.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):529-37

Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma

Ferrer L., Malek E., Bodet-Milin C., Legouill S., Prangère T., Robu D., Jeans S., Tipping J., Huglo D., Carpentier P., Illidge T., Kraeber-Boderé F., Morschhauser F., Bardiès M.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):538-43

Targeted “bone-seeking” radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis

D’angelo G., Sciuto R., Salvatori M., Sperduti I., Mantini G., Maini C. L., Mariani G.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):544-50

Is there need for radioimmunotherapy? Results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab

Forrer F., Oechslin-Oberholzer C., Campana B., Maecke H. R., Mueller-Brand J., Lohri A.

Abstract PDF

SELECTED PRESENTATIONS  THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):551-8

Super-selective hepatic arterial infusions as established technique (‘ARETAIEION’ Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors

Limouris G. S., Karfis I., Chatzioannou A., Paphiti M. I., Lyra M., Gennatas K., Nikou G., Voros D., Pragulidis G. P., Polydorou A. A., Gouliamos A.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):559-68

The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients

Baudino B., D’agata F., Caroppo P., Castellano G., Cauda S., Manfredi M., Geda E., Castelli L., Mortara P., Orsi L., Cauda F., Sacco K., Ardito R. B., Pinessi L., Geminiani G., Torta R., Bisi G.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):569-76

PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?

Skanjeti A., Penna D., Douroukas A., Cistaro A., Arena V., Leo G., Longo G., Traverso A., Belloro S., Pelosi E.

Abstract PDF